Ohta Kensuke相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Teclistamab for multiple pulmonary lesions in extramedullary myeloma: first successful case and review of the literature

替克利司他单抗治疗髓外骨髓瘤多发性肺部病变：首例成功病例及文献回顾

期刊:Annals of Hematology

影响因子:2.4

doi:10.1007/s00277-026-07011-2

Takakuwa, Teruhito; Ohta, Kensuke; Tanada, Yusuke; Okayama, Yusuke; Hino, Masayuki

发表日期：2026

文献求助收藏

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients

淋巴细胞/单核细胞比值可预测伊沙妥昔单抗联合泊马度胺治疗多发性骨髓瘤患者的疗效

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-024-03711-8

Shimazu, Yutaka; Kanda, Junya; Onda, Yoshiyuki; Fuchida, Shin-Ichi; Ohta, Kensuke; Shimura, Yuji; Kosugi, Satoru; Yamamura, Ryosuke; Matsuda, Mitsuhiro; Hanamoto, Hitoshi; Adachi, Yoko; Anzai, Naoyuki; Hotta, Masaaki; Fukushima, Kentaro; Yagi, Hideo; Yoshihara, Satoshi; Tanaka, Yasuhiro; Takakuwa, Teruhito; Tanaka, Hirokazu; Shibayama, Hirohiko; Uoshima, Nobuhiko; Hosen, Naoki; Ito, Tomoki; Shimazaki, Chihiro; Matsumura, Itaru; Kuroda, Junya; Takaori-Kondo, Akifumi; Hino, Masayuki

多发性骨髓瘤

细胞生物学

发表日期：2024

文献求助收藏

Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin

以淋巴细胞计数、κ/λ比值或β2微球蛋白为指标评估elotuzumab治疗多发性骨髓瘤的疗效

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-023-32426-6

Shimazu, Yutaka; Kanda, Junya; Kosugi, Satoru; Ito, Tomoki; Kaneko, Hitomi; Imada, Kazunori; Shimura, Yuji; Fuchida, Shin-Ichi; Fukushima, Kentaro; Tanaka, Hirokazu; Yoshihara, Satoshi; Ohta, Kensuke; Uoshima, Nobuhiko; Yagi, Hideo; Shibayama, Hirohiko; Yamamura, Ryosuke; Tanaka, Yasuhiro; Uchiyama, Hitoji; Onda, Yoshiyuki; Adachi, Yoko; Hanamoto, Hitoshi; Takahashi, Ryoichi; Matsuda, Mitsuhiro; Miyoshi, Takashi; Takakuwa, Teruhito; Hino, Masayuki; Hosen, Naoki; Nomura, Shosaku; Shimazaki, Chihiro; Matsumura, Itaru; Takaori-Kondo, Akifumi; Kuroda, Junya

多发性骨髓瘤

细胞生物学

发表日期：2023

文献求助收藏

Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma Forum

细胞遗传学异常对症状性多发性骨髓瘤的影响：来自关西骨髓瘤论坛的日本真实世界分析

期刊:Leukemia Research Reports

影响因子:0.9

doi:10.1016/j.lrr.2023.100395

Nakaya, Aya; Shibayama, Hirohiko; Uoshima, Nobuhiko; Yamamura, Ryosuke; Yoshioka, Satoshi; Imada, Kazunori; Shimura, Yuji; Hotta, Masaaki; Matsui, Toshimitsu; Kosugi, Satoru; Hanamoto, Hitoshi; Uchiyama, Hitoji; Yoshihara, Satoshi; Fuchida, Shin-Ichi; Onda, Yoshiyuki; Tanaka, Yasuhiro; Ohta, Kensuke; Matsuda, Mitsuhiro; Kanda, Junya; Yoko, Adachi; Kiyota, Miki; Kawata, Eri; Takahashi, Ryoichi; Fukushima, Kentaro; Tanaka, Hirokazu; Yagi, Hideo; Takakuwa, Teruhito; Hosen, Naoki; Ito, Tomoki; Shimazaki, Chihiro; Takaori-Kondo, Akifumi; Kuroda, Junya; Matsumura, Itaru; Hino, Masayuki

多发性骨髓瘤

细胞生物学

发表日期：2023

文献求助收藏

Transcriptomic and functional screening of weapon formation genes implies significance of cell adhesion molecules and female-biased genes in broad-horned flour beetle

武器形成基因的转录组和功能筛选表明细胞粘附分子和雌性偏向基因在宽角面粉甲虫中具有重要意义

期刊:PLoS Genetics

doi:10.1371/journal.pgen.1011069

Miyu Sugiyama, Takane Ozawa, Kunihiro Ohta, Kensuke Okada, Teruyuki Niimi, Katsushi Yamaguchi, Shuji Shigenobu, Yasukazu Okada

细胞生物学

发表日期：2023

文献求助收藏

Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis

卡非佐米-来那度胺-地塞米松和卡非佐米-地塞米松治疗复发/难治性多发性骨髓瘤的真实世界疗效和安全性分析：一项多中心回顾性分析

期刊:Therapeutic Advances in Hematology

影响因子:3.1

doi:10.1177/20406207221104584

Onda, Yoshiyuki; Kanda, Junya; Kaneko, Hitomi; Shimura, Yuji; Fuchida, Shin-Ichi; Nakaya, Aya; Itou, Tomoki; Yamamura, Ryosuke; Tanaka, Hirokazu; Shibayama, Hirohiko; Shimazu, Yutaka; Uchiyama, Hitoji; Yoshihara, Satoshi; Adachi, Yoko; Matsuda, Mitsuhiro; Hanamoto, Hitoshi; Uoshima, Nobuhiko; Kosugi, Satoru; Ohta, Kensuke; Yagi, Hideo; Kanakura, Yuzuru; Matsumura, Itaru; Hino, Masayuki; Nomura, Shosaku; Shimazaki, Chihiro; Takaori-Kondo, Akifumi; Kuroda, Junya

多发性骨髓瘤

发表日期：2022

文献求助收藏

Monocyte or white blood cell counts and β(2) microglobulin predict the durable efficacy of daratumumab with lenalidomide

单核细胞或白细胞计数以及β2微球蛋白水平可预测达雷妥尤单抗联合来那度胺治疗的持久疗效。

期刊:Therapeutic Advances in Hematology

影响因子:3.1

doi:10.1177/20406207221142487

Shimazu, Yutaka; Kanda, Junya; Kaneko, Hitomi; Imada, Kazunori; Yamamura, Ryosuke; Kosugi, Satoru; Shimura, Yuji; Ito, Tomoki; Fuchida, Shin-Ichi; Uchiyama, Hitoji; Fukushima, Kentaro; Yoshihara, Satoshi; Hanamoto, Hitoshi; Tanaka, Hirokazu; Uoshima, Nobuhiko; Ohta, Kensuke; Yagi, Hideo; Shibayama, Hirohiko; Onda, Yoshiyuki; Tanaka, Yasuhiro; Adachi, Yoko; Matsuda, Mitsuhiro; Iida, Masato; Miyoshi, Takashi; Matsui, Toshimitsu; Takahashi, Ryoichi; Takakuwa, Teruhito; Hino, Masayuki; Hosen, Naoki; Nomura, Shosaku; Shimazaki, Chihiro; Matsumura, Itaru; Takaori-Kondo, Akifumi; Kuroda, Junya

细胞生物学

发表日期：2022

文献求助收藏

Dysmegakaryopoiesis and Transient Mild Increase in Bone Marrow Blasts in Patients With Aplastic Anemia Treated With Eltrombopag May Be Signs of Hematologic Improvement and Not Portend Clonal Evolution

接受艾曲波帕治疗的再生障碍性贫血患者中，巨核细胞生成异常和骨髓原始细胞短暂轻度增多可能是血液学改善的标志，而非克隆演变的征兆。

期刊:American Journal of Clinical Pathology

影响因子:1.9

doi:10.1093/ajcp/aqac094

Matsuda, Akira; Imada, Kazunori; Obara, Naoshi; Iida, Hiroatsu; Yamazaki, Hirohito; Tomiyama, Yoshiaki; Miyamura, Koichi; Sasaki, Osamu; Maeda, Tetsuo; Ohta, Kensuke; Usuki, Kensuke; Tokumine, Yukihiro; Imajo, Kenji; Okamoto, Yuji; Murakami, Mami; Nakao, Shinji

细胞生物学

发表日期：2022

文献求助收藏

Phagocytosis of Mature Granulocytes by Bone Marrow Macrophages in an Elderly Man with Adult-Onset Primary Autoimmune Neutropenia

老年男性成人发病型原发性自身免疫性中性粒细胞减少症患者骨髓巨噬细胞对成熟粒细胞的吞噬作用

期刊:Hematology Reports

影响因子:1.2

doi:10.3390/hematolrep14020024

Nishimoto, Mitsutaka; Nakane, Takahiko; Koh, Hideo; Nakashima, Yasuhiro; Yamamura, Ryosuke; Nakamae, Hirohisa; Hino, Masayuki; Ohta, Kensuke

免疫/内分泌

细胞生物学

中性粒细胞

发表日期：2022

文献求助收藏

Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum

HDT/ASCT 后维持治疗对症状性多发性骨髓瘤患者的意义：关西骨髓瘤论坛的多中心回顾性分析

影响因子:1.2

doi:10.1002/jha2.284

Nakaya, Aya; Shibayama, Hirohiko; Nakatani, Eiji; Shimura, Yuji; Kosugi, Satoru; Tanaka, Hirokazu; Fuchida, Shin-Ichi; Kanda, Junya; Uoshima, Nobuhiko; Kaneko, Hitomi; Imada, Kazunori; Ohta, Kensuke; Ito, Tomoki; Yagi, Hideo; Yoshihara, Satoshi; Hino, Masayuki; Shimazaki, Chihiro; Takaori-Kondo, Akifumi; Kuroda, Junya; Matsumura, Itaru; Kanakura, Yuzuru; Nomura, Shosaku

多发性骨髓瘤

发表日期：2021

文献求助收藏